Become a member of BioTechniques (it's free!) and receive the latest news in the life sciences, member-exclusives and 10% off BioTechniques article processing fees

Tech Blast | CAR-T cell therapy development: from personalized to off the shelf approaches

Cancer research Cell and tissue biology Drug discovery and development Immunology

In this Tech Blast episode, we talk CAR-T cell development for cancer immunotherapies with Ritwika Biswas, Product Scientist for Sino Biological. We cover some of the latest developments in the field, the advantages of CAR-T over other immunotherapies and selecting the perfect CAR-T antigen, amongst a whole host of different aspects in the field.

Contents

  • Introduction: 00:00-00:30
  • Core principles of cancer immunotherapy: 00:30-02:00
  • Explaining cancer immunity: 02:00-03:20
  • Distinguishing CAR-T from native T cells: 03:20-04:40
  • CAR-T antigen targets: 04:40-06:00
  • Techniques for engineering CAR-T cells: 06:00-08:00
  • Introducing off the shelf CAR-T cells: 08:00-09:45
  • Addressing challenges in off the shelf CAR-T: 09:45-11:30
  • Current status of CAR-T therapies: 11:30-12:55
  • Advantages of CAR-T cell therapy over other immunotherapies: 12:55-15:25
  • The future of CAR-T: 15:10-18:11

This feature was supported by Sino Biological.